C

CG Oncology Inc
NASDAQ:CGON

Watchlist Manager
CG Oncology Inc
NASDAQ:CGON
Watchlist
Price: 40.94 USD -1.61% Market Closed
Market Cap: 3.3B USD

Wall Street
Price Targets

CGON Price Targets Summary
CG Oncology Inc

Wall Street analysts forecast CGON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGON is 73.1 USD with a low forecast of 55.55 USD and a high forecast of 105 USD.

Lowest
Price Target
55.55 USD
36% Upside
Average
Price Target
73.1 USD
79% Upside
Highest
Price Target
105 USD
156% Upside
CG Oncology Inc Competitors:
Price Targets
206650
EuBiologics Co Ltd
58% Upside
RYTM
Rhythm Pharmaceuticals Inc
13% Upside
NTLA
Intellia Therapeutics Inc
145% Upside
LCTX
Lineage Cell Therapeutics Inc
145% Upside
RPTX
Repare Therapeutics Inc
43% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
25% Upside
IVVD
Invivyd Inc
222% Upside
RXRX
Recursion Pharmaceuticals Inc
49% Upside

Revenue
Forecast

Revenue Estimate
CG Oncology Inc

For the last 2 years the compound annual growth rate for CG Oncology Inc's revenue is 144%. The projected CAGR for the next 4 years is 332%.

144%
Past Growth
332%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CG Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CG Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CGON's stock price target?
Price Target
73.1 USD

According to Wall Street analysts, the average 1-year price target for CGON is 73.1 USD with a low forecast of 55.55 USD and a high forecast of 105 USD.

What is CG Oncology Inc's Revenue forecast?
Projected CAGR
332%

For the last 2 years the compound annual growth rate for CG Oncology Inc's revenue is 144%. The projected CAGR for the next 4 years is 332%.

Back to Top